Monitor for potential downward pressure on sentiment; CEO participation in sales raises concern. Check for upcoming earnings, guidance changes, or regulatory filings that may have triggered this activity.
How the stock moved after the report
BEARISH VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Mar 6 $46.94entry
- T+1 · 8mo ago +2.96%α +2.12% · $48.33
- T+5 · 8mo ago −7.80%α −6.27% · $43.28
- T+20 · 7mo ago +9.03%α +11.08% · $51.18
- T+60 · 6mo ago +44.57%α +31.79% · $67.86
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Three insiders at Twist Bioscience sold shares in a coordinated 7-day window, including CEO Emily Leproust, who sold $112.5K worth of stock. All transactions were open-market sales at the same price, totaling $175,629 in aggregate.
Key Financial Metrics
Key Facts
- CEO Emily Leproust sold $112,490 worth of shares in an open-market transaction.
- SVP of HR Paula Green sold $43,408 worth of shares; Dennis Cho sold $19,731.
- All three sales occurred on the same day (2026-03-06) at $46.426 per share.
- Total open-market sales in the cluster: $175,629 across 3,783 shares.
- No purchases or non-cash transactions (e.g., A, F, M) were reported in this cluster.
Financial Impact
$175,629 in insider sales over 7 days
Risk Factors
- Insider selling, especially by the CEO, may signal lack of confidence in near-term prospects.
- Pattern could attract negative market attention if followed by further divestitures.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CONTEXT: Insider Cluster Data (3 trades, 7d window) | cluster-TWST-1773173151611 |
Track record
47 reports on TWST
8 of 10 bullish or bearish reports moved the stock their way by T+20. Best: +55.24% at T+60 after the Aug 3, 2026 report. 9 of 11 went positive at some point.
Filters
- Nov 16, 2026today 144 Neutral 2/10 Entry $105.03 Now $105.04 +0.01% settles Dec 15
- Nov 16, 2026today 144 Neutral 2/10 Entry $105.16 Now $105.04 −0.11% settles Dec 15
- Nov 16, 2026today 144 Neutral 2/10 Entry $104.98 Now $105.04 +0.06% settles Dec 15
- Nov 16, 2026today 144 Neutral 2/10 Entry $105.61 Now $105.04 −0.54% settles Dec 15
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $104.03 Now $105.04 +0.98% settles Dec 15
- Nov 12, 20264d ago 8-K Bullish 6/10 Entry $114.22 Now $105.04 −8.04% settles Dec 11
- Nov 12, 20264d ago SC 13G/A Neutral 2/10 Entry $114.22 Now $105.04 −8.04% settles Dec 11
- Nov 10, 20266d ago SC 13G Neutral 3/10 Entry $132.13 Now $105.04 −20.50% settles Dec 9
- Nov 5, 202611d ago Insider Cluster Neutral 2/10 Entry $120.79 Now $105.04 −13.04% settles Dec 7
- Nov 5, 202611d ago SC 13G/A Neutral 2/10 Entry $120.61 Now $105.04 −12.91% settles Dec 4
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers